[^1]
| ABCD3 |
|---|
| Gene | [ABCD3](/genes/abcd3) |
| UniProt ID | [O75323](https://www.uniprot.org/uniprot/O75323) |
| PDB Structure | 7B7D |
| Molecular Weight | 79.7 kDa |
| Subcellular Localization | Peroxisomal membrane |
| Protein Family | ABC transporter subfamily D |
ABCD3 Protein is a peroxisomal ATP-binding cassette (ABC) transporter involved in the import of very long-chain fatty acids (VLCFAs) and other metabolites into peroxisomes. The protein is encoded by the ABCD3 gene located on chromosome 1p22.1 and is expressed in multiple tissues, with highest levels in liver, kidney, and brain.
ABCD3 is a peroxisomal membrane protein with characteristic ABC transporter architecture:
- Nucleotide-binding domain (NBD): Two NBDs containing Walker A (P-loop) and Walker B motifs
- ABC signature (C-loop): Consensus sequence specific to ABC transporters
- Transmembrane domains: Six alpha-helical transmembrane segments
- N-terminal membrane-anchored domain: Contains multiple transmembrane segments
The protein functions as a homodimer to form an active transporter complex in the peroxisomal membrane.
ABCD3 transports various substrates into peroxisomes:
| Substrate |
Metabolic Pathway |
Importance |
| Very long-chain fatty acids (VLCFAs, C22+) |
β-oxidation |
Energy production |
| Branched-chain fatty acids |
Metabolism |
Brain lipid homeostasis |
| Dicarboxylic acids |
ω-oxidation |
Detoxification |
| Bile acid intermediates |
Synthesis |
Liver function |
| Polyunsaturated fatty acids |
Membrane composition |
Neuronal health |
- Liver: Primary site of VLCFA β-oxidation
- Kidney: Fatty acid metabolism
- Brain: Very long-chain fatty acid homeostasis critical for neuronal membranes
Peroxisomes are essential for neuronal health:
- VLCFA oxidation prevents toxic accumulation
- Plasmalogen synthesis for myelin
- ROS detoxification via catalase
- Docosahexaenoic acid (DHA) metabolism
ABCD3 dysfunction may contribute to AD pathogenesis:
- Lipid homeostasis disruption: Altered neuronal membrane composition
- VLCFA accumulation: Lipotoxicity and oxidative stress
- Impaired peroxisomal function: Energy deficit
- Myelin abnormalities: White matter changes
Peroxisomal dysfunction also affects PD:
- Mitochondrial-peroxisomal cross-talk
- Lipid metabolism in dopaminergic neurons
- α-Synuclein interaction with peroxisomes
While ABCD3 mutations are not common causes of neurodegeneration:
- Polymorphisms may modify disease risk
- Expression changes observed in AD/PD brains
- Potential modifier gene role
Peroxisomal ABC transporters are potential drug targets:
- Modulators: Compounds enhancing transporter function
- Substrate reduction: Decreasing VLCFA burden
- Gene therapy: Restoring ABCD3 expression
ABCD3 expression may serve as:
- Peroxisomal function indicator
- Disease progression marker
- Therapeutic response biomarker
ABCD3 is essential for peroxisome function:
- Import of membrane proteins
- Peroxisome proliferation
- Matrix protein import coordination
- Organelle quality control
Peroxisomal dysfunction causes:
- Zellweger spectrum disorders
- X-linked adrenoleukodystrophy
- Refsum disease
- Modified risk in metabolic syndrome
Strategies for treating peroxisomal disorders:
- Loren gene therapy: Restoring ABCD function
- Substrate reduction therapy: Lowering VLCFA burden
- Anti-oxidant treatment: Reducing oxidative stress
- Lifestyle interventions: Diet modification
ABCD3 as a disease biomarker:
- Expression levels in blood
- Fibroblast function assays
- VLCFA measurements
- Imaging biomarkers